Open AccessDoes gemcitabine-based combination therapy improve the prognosis of unresectable pancreatic cancer?
Author(s) -
Chen Sun
Publication year - 2012
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v18.i35.4944
Subject(s) - gemcitabine , medicine , combination therapy , pancreatic cancer , neutropenia , gastroenterology , oncology , hazard ratio , confidence interval , chemotherapy , cancer
To assess whether gemcitabine-based combination therapy improves the prognosis of unresectable pancreatic cancer compared with gemcitabine treatment alone.